ATE443129T1 - Kulturmedium namens mv06 sowohl für endothel- als auch für myokardzellen - Google Patents
Kulturmedium namens mv06 sowohl für endothel- als auch für myokardzellenInfo
- Publication number
- ATE443129T1 ATE443129T1 AT07024860T AT07024860T ATE443129T1 AT E443129 T1 ATE443129 T1 AT E443129T1 AT 07024860 T AT07024860 T AT 07024860T AT 07024860 T AT07024860 T AT 07024860T AT E443129 T1 ATE443129 T1 AT E443129T1
- Authority
- AT
- Austria
- Prior art keywords
- endothelial
- culture media
- myocardial cells
- media called
- growth factor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/645,482 US7754486B2 (en) | 2006-12-26 | 2006-12-26 | Culture medium named MV06 for both endothelial and myocardiac cells |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE443129T1 true ATE443129T1 (de) | 2009-10-15 |
Family
ID=39185837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07024860T ATE443129T1 (de) | 2006-12-26 | 2007-12-21 | Kulturmedium namens mv06 sowohl für endothel- als auch für myokardzellen |
Country Status (7)
Country | Link |
---|---|
US (1) | US7754486B2 (de) |
EP (1) | EP1939277B1 (de) |
JP (1) | JP2008161183A (de) |
AT (1) | ATE443129T1 (de) |
DE (1) | DE602007002464D1 (de) |
ES (1) | ES2333618T3 (de) |
PL (1) | PL1939277T3 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8574567B2 (en) | 2007-05-03 | 2013-11-05 | The Brigham And Women's Hospital, Inc. | Multipotent stem cells and uses thereof |
WO2008137115A1 (en) | 2007-05-03 | 2008-11-13 | The Brigham And Women's Hospital, Inc. | Multipotent stem cells and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08205860A (ja) * | 1994-01-21 | 1996-08-13 | Usa Government | 造血細胞の膨大化および移植方法 |
US6110459A (en) * | 1997-05-28 | 2000-08-29 | Mickle; Donald A. G. | Transplants for myocardial scars and methods and cellular preparations |
EP1469064A1 (de) * | 2003-04-15 | 2004-10-20 | DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH | Expression von Proteinen in endothelialen Zellen, die von Vorläuferzellen aus Nabelschnurblut abgeleitet wurden |
US20060166361A1 (en) * | 2004-12-21 | 2006-07-27 | Agnieszka Seyda | Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same |
-
2006
- 2006-12-26 US US11/645,482 patent/US7754486B2/en active Active
-
2007
- 2007-11-30 JP JP2007311730A patent/JP2008161183A/ja active Pending
- 2007-12-21 AT AT07024860T patent/ATE443129T1/de not_active IP Right Cessation
- 2007-12-21 ES ES07024860T patent/ES2333618T3/es active Active
- 2007-12-21 PL PL07024860T patent/PL1939277T3/pl unknown
- 2007-12-21 EP EP07024860A patent/EP1939277B1/de active Active
- 2007-12-21 DE DE602007002464T patent/DE602007002464D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
EP1939277B1 (de) | 2009-09-16 |
US20080153164A1 (en) | 2008-06-26 |
US7754486B2 (en) | 2010-07-13 |
EP1939277A1 (de) | 2008-07-02 |
ES2333618T3 (es) | 2010-02-24 |
JP2008161183A (ja) | 2008-07-17 |
DE602007002464D1 (de) | 2009-10-29 |
PL1939277T3 (pl) | 2010-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Grayson et al. | Human mesenchymal stem cells tissue development in 3D PET matrices | |
Yin et al. | Stepwise differentiation of mesenchymal stem cells augments tendon-like tissue formation and defect repair in vivo | |
Betre et al. | Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide | |
Xiao et al. | Upregulation of Flk-1 by bFGF via the ERK pathway is essential for VEGF-mediated promotion of neural stem cell proliferation | |
Cooke et al. | Structured three-dimensional co-culture of mesenchymal stem cells with chondrocytes promotes chondrogenic differentiation without hypertrophy | |
Chen et al. | Stepwise differentiation of human embryonic stem cells promotes tendon regeneration by secreting fetal tendon matrix and differentiation factors | |
Chen et al. | Tendon derived stem cells promote platelet-rich plasma healing in collagenase-induced rat achilles tendinopathy | |
Rutgers et al. | Effect of collagen type I or type II on chondrogenesis by cultured human articular chondrocytes | |
Simkin et al. | The mammalian blastema: regeneration at our fingertips | |
Chun et al. | Identification and characterization of bioactive factors in bladder submucosa matrix | |
Toh et al. | Combined effects of TGFβ1 and BMP2 in serum-free chondrogenic differentiation of mesenchymal stem cells induced hyaline-like cartilage formation | |
Kim et al. | Enhanced proliferation and chondrogenic differentiation of human synovium-derived stem cells expanded with basic fibroblast growth factor | |
Wang et al. | The critical role of ECM proteins within the human MSC niche in endothelial differentiation | |
Raghavan et al. | Optimization of human tendon tissue engineering: synergistic effects of growth factors for use in tendon scaffold repopulation | |
Kim et al. | Hepatic patch by stacking patient-specific liver progenitor cell sheets formed on multiscale electrospun fibers promotes regenerative therapy for liver injury | |
Mouthuy et al. | Layering PLGA‐based electrospun membranes and cell sheets for engineering cartilage–bone transition | |
Hutton et al. | Hypoxia inhibits de novo vascular assembly of adipose-derived stromal/stem cell populations, but promotes growth of preformed vessels | |
Lin et al. | Sonic hedgehog improves redifferentiation of dedifferentiated chondrocytes for articular cartilage repair | |
US20140079739A1 (en) | Derivation of fibrochondrocytes from progenitor cells | |
Chai et al. | Fine-tuning pro-angiogenic effects of cobalt for simultaneous enhancement of vascular endothelial growth factor secretion and implant neovascularization | |
Arora et al. | Pericellular plasma clot negates the influence of scaffold stiffness on chondrogenic differentiation | |
Ahmed et al. | Cartilage tissue formation using redifferentiated passaged chondrocytes in vitro | |
Pufe et al. | Programmable cells of monocytic origin (PCMO): A source of peripheral blood stem cells that generate collagen type II‐producing chondrocytes | |
Sternberg et al. | A human embryonic stem cell-derived clonal progenitor cell line with chondrogenic potential and markers of craniofacial mesenchyme | |
Hou et al. | Dominant role of in situ native cartilage niche for determining the cartilage type regenerated by BMSCs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |